P 2018

Pyrazolotriazines as inhibitors of nucleases

DAMBORSKÝ, Jiří, Fedor NIKULENKOV, Alexandra SISÁKOVÁ, Štěpán HAVEL, Lumír KREJČÍ et. al.

Basic information

Original name

Pyrazolotriazines as inhibitors of nucleases

Authors

DAMBORSKÝ, Jiří (203 Czech Republic, belonging to the institution), Fedor NIKULENKOV (203 Czech Republic, belonging to the institution), Alexandra SISÁKOVÁ (703 Slovakia, belonging to the institution), Štěpán HAVEL (203 Czech Republic, belonging to the institution), Lumír KREJČÍ (203 Czech Republic, belonging to the institution), Benoit Jean-Pierre CARBAIN (250 France, belonging to the institution), Jan BREZOVSKÝ (203 Czech Republic, belonging to the institution), Lukáš DANIEL (203 Czech Republic, belonging to the institution) and Kamil PARUCH (203 Czech Republic, belonging to the institution)

Edition

Number: US 9969741 B2, Publisher: USPTO, Place of publication: USA, Owner's name: Masarykova univerzita, 2018

Other information

Language

English

Type of outcome

Patent

Field of Study

10400 1.4 Chemical sciences

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

RIV identification code

RIV/00216224:14310/18:00105284

Organization unit

Faculty of Science

Keywords in English

inhibitor; nuclease; DNA repair; pyrazolotriazine; MUS81

Tags

Změněno: 13/4/2019 15:10, doc. Mgr. Kamil Paruch, Ph.D.

Abstract

V originále

The present invention relates to substituted heterocycles as inhibitors of nudeases MUS81 and MRE11, pharmaceutical compositions containing the compounds, and pharmaceutical use of the compounds and compositions in the treatment of the diseases such as, for example, cancer.

Links

LM2015063, research and development project
Name: Národní infrastruktura chemické biologie (Acronym: CZ-­OPENSCREEN)
Investor: Ministry of Education, Youth and Sports of the CR
MUNI/M/1894/2014, interní kód MU
Name: Development of new MUS81 nuclease inhibitors as chemical biology probe with clinical progression
Investor: Masaryk University, INTERDISCIPLINARY - Interdisciplinary research projects